BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26833153)

  • 21. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS; Helfer VE; Bernardes PM; Macedo AJ; Nielsen EI; Friberg LE; Dalla Costa T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
    Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill
    Sweeney E; Sabnis A; Edwards AM; Harrison F
    Microbiology (Reading); 2020 Dec; 166(12):1171-1180. PubMed ID: 33253080
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellulose Nanofibril Formulations Incorporating a Low-Molecular-Weight Alginate Oligosaccharide Modify Bacterial Biofilm Development.
    Jack AA; Nordli HR; Powell LC; Farnell DJJ; Pukstad B; Rye PD; Thomas DW; Chinga-Carrasco G; Hill KE
    Biomacromolecules; 2019 Aug; 20(8):2953-2961. PubMed ID: 31251598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted disruption of the extracellular polymeric network of
    Powell LC; Pritchard MF; Ferguson EL; Powell KA; Patel SU; Rye PD; Sakellakou SM; Buurma NJ; Brilliant CD; Copping JM; Menzies GE; Lewis PD; Hill KE; Thomas DW
    NPJ Biofilms Microbiomes; 2018; 4():13. PubMed ID: 29977590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model.
    Laulund ASB; Trøstrup H; Lerche CJ; Thomsen K; Christophersen L; Calum H; Høiby N; Moser C
    Pathog Dis; 2020 Jul; 78(5):. PubMed ID: 31116394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa.
    Powell LC; Pritchard MF; Emanuel C; Onsøyen E; Rye PD; Wright CJ; Hill KE; Thomas DW
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):483-92. PubMed ID: 24074505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
    Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy.
    Gnanadhas DP; Elango M; Datey A; Chakravortty D
    Sci Rep; 2015 Nov; 5():16043. PubMed ID: 26521707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system.
    Komor U; Bielecki P; Loessner H; Rohde M; Wolf K; Westphal K; Weiss S; Häussler S
    Microbes Infect; 2012 Sep; 14(11):951-8. PubMed ID: 22542841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.